Optimizing 3-dimensional human skin models to facilitate long-term development of Onchocerca volvulus, a debilitating obligatory human parasite

Onchocerciasis also known as river blindness is a neglected tropical disease and the world’s second-leading infectious cause of blindness in humans; it is caused by Onchocerca volvulus. Current therapies kill microfilariae but fail to kill the adult parasites, which reside within subcutaneous nodules. To support a more target-driven drug development that can also cure and thus support the elimination of this disease, an in-depth understanding of O. volvulus biology especially the factors that support the longevity of these worms in the human host (>10 years) is required. However, research is hampered by a lack of access to adult worms. O. volvulus is an obligatory human parasite and no small animal models that can propagate this parasite were successfully developed. The current optimized 2-dimensional (2-D) in vitro culturing method starting with O. volvulus infective larvae does not yet support the development of mature adult worms. To overcome these limitations, we have developed 3-dimensional (3-D) culture systems that simulated the human in vivo niche using in vitro engineered skin and adipose tissue. We show that an optimized indirect co-culture of in vitro skin tissue with fourth-stage larvae supported a significant increase in growth until the pre-adult stage with a median length of 816 – 831 μm as compared to 767 μm of 2-D cultured larvae. Notably, when larvae were co-cultured directly with adipose tissue models, a significant improvement for larval motility and thus fitness was observed; 95 % compared to 26 % in the 2-D system. These promising co-culture concepts are a first step to further improve the long-term development of adult worms in vitro, and thus provide the filarial research community with a valuable source of O. volvulus worms at various developmental stages, which may accelerate innovative unsolved biomedical inquiries into the parasite’s biology. Author summary The filarial nematode Onchocerca volvulus is an obligatory human parasite and the causative agent of onchocerciasis, better known as river blindness. In 2017, more than 20 million infections with O. volvulus were estimated worldwide, 99 % of the patients live in Africa. Current international control programs focus on the reduction of microfilaridermia by mass drug administration of ivermectin. However, to meet the elimination goals, additional therapy strategies are needed that also target the adult worms. As this parasite is obliged to humans, there are no small animal models that sustain the full life cycle of the parasite, thus greatly impeding the research on this filarial nematode. To overcome these drawbacks, we developed co-culture systems based on engineered human skin and adipose tissue that represent the in vivo niche of O. volvulus in which we were able to establish improved conditions of culturing to the pre-adult stages of the parasite. Furthermore, our new culture approach could significantly reduce the use of animal models currently used for drug testing of surrogate larvae.

[1]  R. Maizels,et al.  Organoids – New Models for Host–Helminth Interactions , 2019, Trends in Parasitology.

[2]  D. Bowman,et al.  ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months , 2019, Parasites & Vectors.

[3]  A. Hoerauf,et al.  Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents , 2019, Parasites & Vectors.

[4]  D. Voronin,et al.  Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms , 2019, PLoS neglected tropical diseases.

[5]  S. Bennuru,et al.  Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum , 2018, PLoS neglected tropical diseases.

[6]  P. Enyong,et al.  Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa , 2018, Parasites & Vectors.

[7]  A. Hoerauf,et al.  Successful long-term maintenance of Mansonella perstans in an in vitro culture system , 2017, Parasites & Vectors.

[8]  H. Evans,et al.  Endothelial cells release soluble factors that support the long-term survival of filarial worms in vitro , 2016, Experimental parasitology.

[9]  S. Edwards,et al.  Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis , 2016, Scientific Reports.

[10]  H. Walles,et al.  In vitro chemotaxis and tissue remodeling assays quantitatively characterize foreign body reaction. , 2016, ALTEX.

[11]  B. De Wever,et al.  Alternative methods for the replacement of eye irritation testing. , 2015, ALTEX.

[12]  Young Eun Kim,et al.  Control, Elimination, and Eradication of River Blindness: Scenarios, Timelines, and Ivermectin Treatment Needs in Africa , 2015, PLoS neglected tropical diseases.

[13]  C. Unger,et al.  Development and application of three-dimensional skin equivalents for the investigation of percutaneous worm invasion. , 2015, Experimental parasitology.

[14]  H. Walles,et al.  Impedance Spectroscopy for the Non-Destructive Evaluation of In Vitro Epidermal Models , 2014, Pharmaceutical Research.

[15]  M. Bradley,et al.  Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms , 2014, Parasites & Vectors.

[16]  J. Cano,et al.  Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping , 2014, Parasites & Vectors.

[17]  P. Hotez,et al.  Elimination and Eradication of Neglected Tropical Diseases with Mass Drug Administrations: A Survey of Experts , 2013, PLoS neglected tropical diseases.

[18]  H. Evans,et al.  A Comprehensive, Model-Based Review of Vaccine and Repeat Infection Trials for Filariasis , 2013, Clinical Microbiology Reviews.

[19]  Florian Groeber,et al.  Bioreactors in tissue engineering—principles, applications and commercial constraints , 2013, Biotechnology journal.

[20]  L. Konaté,et al.  Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal , 2012, PLoS neglected tropical diseases.

[21]  Teruo Okano,et al.  Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case , 2012, Surgery Today.

[22]  A. Hopkins,et al.  Onchocerciasis in the Americas: from arrival to (near) elimination , 2011, Parasites & Vectors.

[23]  A. Hoerauf,et al.  Lymphatic Vascularisation and Involvement of Lyve-1+ Macrophages in the Human Onchocerca Nodule , 2009, PloS one.

[24]  L. Konaté,et al.  Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.

[25]  A. Hoerauf,et al.  Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. , 2001, Microbes and infection.

[26]  M Liebsch,et al.  The ECVAM International Validation Study on In Vitro Tests for Skin Corrosivity. 2. Results and Evaluation by the Management Team. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  M. Trpiš,et al.  Survival and development of larval Onchocerca volvulus in diffusion chambers implanted in primate and rodent hosts. , 1993, The Journal of parasitology.

[28]  H. Schulz-Key,et al.  The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. , 1988, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[29]  D. Orgill,et al.  Current Available Cellular and Tissue-Based Products for Treatment of Skin Defects. , 2019, Advances in skin & wound care.

[30]  P. Hotez,et al.  Onchocerca volvulus: The Road from Basic Biology to a Vaccine. , 2018, Trends in parasitology.

[31]  S. Thomas,et al.  Optimization of culture and analysis methods for enhancing long-term Brugia malayi survival, molting and motility in vitro , 2018 .

[32]  Christian Reuter,et al.  Preparation of a Three-Dimensional Full Thickness Skin Equivalent. , 2017, Methods in molecular biology.

[33]  Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015 .

[34]  Burkina Faso,et al.  Address of Strategic and technical issues for the launch of APOC new structure The Technical Consultative Committee (TCC) of the African Programme for Onchocerciasis Control (APOC) will meet for its 39 th session from 8 to 12 September , 2014 .

[35]  G. Frühbeck Overview of adipose tissue and its role in obesity and metabolic disorders. , 2008, Methods in molecular biology.

[36]  N. Brattig Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. , 2004, Microbes and infection.